Back
The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma Multiforme
Stanislaw R. Burzynski, Sonali S. Patil
J. Cancer Ther. Vol.5 No.10, September 04, 2014  DOI: 10.4236/jct.2014.510099
       (PDF  4262K)     HTML     
A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents
Stanislaw R. Burzynski, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.6 No.1, January 08, 2015  DOI: 10.4236/jct.2015.61006
       (PDF  2621K)     HTML      XML
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.8 No.2, February 16, 2017  DOI: 10.4236/jct.2017.82015
       (PDF  452K)     HTML      XML
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.5 No.12, October 29, 2014  DOI: 10.4236/jct.2014.512116
       (PDF  3640K)     HTML     
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with High-Grade Glioma. Final Report (Protocol BT-06), and Review of Recent Trials
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.5 No.6, May 26, 2014  DOI: 10.4236/jct.2014.56065
       (PDF  580K)     HTML     
 
 
Top